跳到正文

EPRX — Eupraxia Pharmaceuticals Inc 机构持仓 · 2026年Q2

谁持有 Eupraxia Pharmaceuticals Inc(EPRX)?2026年Q2(报告期截至 2026-06-30)共有 73 家机构在 SEC 13F 申报中报告持有,合计 1.64 亿美元。前几大持有机构:Beutel, Goodman & Co Ltd.(2,380.00 万美元)、Affinity Asset Advisors, LLC(1,090.00 万美元)、Balyasny Asset Management L.P.(890.00 万美元)。

排名机构市值股数变动
1Beutel, Goodman & Co Ltd.$23.8M3.6M减持
2Affinity Asset Advisors, LLC$10.9M1.6M增持
3Balyasny Asset Management L.P.$8.9M1.4M增持
4Vivo Capital, LLC$8.9M1.4M持平
5SCOTIA CAPITAL INC.$8.8M1.3M增持
6PFM Health Sciences, LP$8.0M1.2M增持
7GREAT POINT PARTNERS LLC$7.9M1.2M持平
8Jupiter Topco LLC$6.9M1.0M新建仓
9Rubric Capital Management LP$5.7M867,424增持
10Ikarian Capital, LLC$5.4M809,741减持
11Woodline Partners LP$4.9M746,864增持
12Point72 Asset Management, L.P.$4.8M730,284减持
13AMERIPRISE FINANCIAL INC$4.7M711,024增持
14Redmile Group, LLC$4.0M611,400减持
15Seven Fleet Capital Management LP$4.0M610,785减持
16UBS Group AG$3.4M519,211减持
17CITADEL ADVISORS LLC$3.3M502,011增持
18MILLENNIUM MANAGEMENT LLC$2.9M441,586新建仓
19Alyeska Investment Group, L.P.$2.5M375,000持平
20PICTON MAHONEY ASSET MANAGEMENT$2.4M360,878新建仓
21Velan Capital Investment Management LP$2.3M352,000持平
22JANE STREET GROUP, LLC$2.2M329,053增持
23Aisling Capital Management LP$2.1M325,000持平
24SummitTX Capital, L.P.$2.1M318,784减持
25Royal Bank of Canada$2.1M311,435增持

来源:SEC 13F 申报文件 · 截至 2026-06-30